Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood
Abstract The objective of this study was to evaluate whether juvenile fluoxetine (FLX) exposure induces long-term changes in baseline responses to anxiety-inducing environments, and if so, whether its re-exposure in adulthood would ameliorate this anxiety-like phenotype. An additional goal was to as...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80c4ded134d041aa88cdd77b4d2e9863 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:80c4ded134d041aa88cdd77b4d2e9863 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:80c4ded134d041aa88cdd77b4d2e98632021-12-02T18:15:25ZAdolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood10.1038/s41598-021-87378-62045-2322https://doaj.org/article/80c4ded134d041aa88cdd77b4d2e98632021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87378-6https://doaj.org/toc/2045-2322Abstract The objective of this study was to evaluate whether juvenile fluoxetine (FLX) exposure induces long-term changes in baseline responses to anxiety-inducing environments, and if so, whether its re-exposure in adulthood would ameliorate this anxiety-like phenotype. An additional goal was to assess the impact of adolescent FLX pretreatment, and its re-exposure in adulthood, on serotonin transporters (5-HTT) and brain-derived-neurotrophic-factor (BDNF)-related signaling markers (TrkB-ERK1/2-CREB-proBDNF-mBDNF) within the hippocampus and prefrontal cortex. To do this, female C57BL/6 mice were exposed to FLX in drinking water during postnatal-days (PD) 35–49. After a 21-day washout-period (PD70), mice were either euthanized (tissue collection) or evaluated on anxiety-related tests (open field, light/dark box, elevated plus-maze). Juvenile FLX history resulted in a persistent avoidance-like profile, along with decreases in BDNF-signaling markers, but not 5-HTTs or TrkB receptors, within both brain regions. Interestingly, FLX re-exposure in adulthood reversed the enduring FLX-induced anxiety-related responses across all behavioral tasks, while restoring ERK2-CREB-proBDNF markers to control levels and increasing mBDNF within the prefrontal cortex, but not the hippocampus. Collectively, these results indicate that adolescent FLX history mediates neurobehavioral adaptations that endure into adulthood, which are indicative of a generalized anxiety-like phenotype, and that this persistent effect is ameliorated by later-life FLX re-exposure, in a prefrontal cortex-specific manner.Francisco J. Flores-RamirezAnapaula ThemannJorge A. Sierra-FonsecaIsrael Garcia-CarachureSamuel A. CastilloMinerva RodriguezOmar LiraJoshua Preciado-PiñaBrandon L. WarrenAlfred J. RobisonSergio D. IñiguezNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Francisco J. Flores-Ramirez Anapaula Themann Jorge A. Sierra-Fonseca Israel Garcia-Carachure Samuel A. Castillo Minerva Rodriguez Omar Lira Joshua Preciado-Piña Brandon L. Warren Alfred J. Robison Sergio D. Iñiguez Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood |
description |
Abstract The objective of this study was to evaluate whether juvenile fluoxetine (FLX) exposure induces long-term changes in baseline responses to anxiety-inducing environments, and if so, whether its re-exposure in adulthood would ameliorate this anxiety-like phenotype. An additional goal was to assess the impact of adolescent FLX pretreatment, and its re-exposure in adulthood, on serotonin transporters (5-HTT) and brain-derived-neurotrophic-factor (BDNF)-related signaling markers (TrkB-ERK1/2-CREB-proBDNF-mBDNF) within the hippocampus and prefrontal cortex. To do this, female C57BL/6 mice were exposed to FLX in drinking water during postnatal-days (PD) 35–49. After a 21-day washout-period (PD70), mice were either euthanized (tissue collection) or evaluated on anxiety-related tests (open field, light/dark box, elevated plus-maze). Juvenile FLX history resulted in a persistent avoidance-like profile, along with decreases in BDNF-signaling markers, but not 5-HTTs or TrkB receptors, within both brain regions. Interestingly, FLX re-exposure in adulthood reversed the enduring FLX-induced anxiety-related responses across all behavioral tasks, while restoring ERK2-CREB-proBDNF markers to control levels and increasing mBDNF within the prefrontal cortex, but not the hippocampus. Collectively, these results indicate that adolescent FLX history mediates neurobehavioral adaptations that endure into adulthood, which are indicative of a generalized anxiety-like phenotype, and that this persistent effect is ameliorated by later-life FLX re-exposure, in a prefrontal cortex-specific manner. |
format |
article |
author |
Francisco J. Flores-Ramirez Anapaula Themann Jorge A. Sierra-Fonseca Israel Garcia-Carachure Samuel A. Castillo Minerva Rodriguez Omar Lira Joshua Preciado-Piña Brandon L. Warren Alfred J. Robison Sergio D. Iñiguez |
author_facet |
Francisco J. Flores-Ramirez Anapaula Themann Jorge A. Sierra-Fonseca Israel Garcia-Carachure Samuel A. Castillo Minerva Rodriguez Omar Lira Joshua Preciado-Piña Brandon L. Warren Alfred J. Robison Sergio D. Iñiguez |
author_sort |
Francisco J. Flores-Ramirez |
title |
Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood |
title_short |
Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood |
title_full |
Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood |
title_fullStr |
Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood |
title_full_unstemmed |
Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood |
title_sort |
adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female c57bl/6 mice that is ameliorated by fluoxetine re-exposure in adulthood |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/80c4ded134d041aa88cdd77b4d2e9863 |
work_keys_str_mv |
AT franciscojfloresramirez adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT anapaulathemann adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT jorgeasierrafonseca adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT israelgarciacarachure adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT samuelacastillo adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT minervarodriguez adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT omarlira adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT joshuapreciadopina adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT brandonlwarren adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT alfredjrobison adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood AT sergiodiniguez adolescentfluoxetinetreatmentmediatesapersistentanxietylikeoutcomeinfemalec57bl6micethatisamelioratedbyfluoxetinereexposureinadulthood |
_version_ |
1718378403197878272 |